OXSORALEN

This brand name is authorized in Austria, Brazil, Japan, Malta, Poland, United States

Active ingredients

The drug OXSORALEN contains one active pharmaceutical ingredient (API):

1 Methoxsalen
UNII U4VJ29L7BQ - METHOXSALEN

Methoxsalen, upon photoactivation, conjugates and forms covalent bonds with DNA which leads to the formation of both monofunctional (addition to a single strand of DNA) and bifunctional adducts (crosslinking of psoralen to both strands of DNA). Reactions with proteins have also been described. The formation of photoadducts results in inhibition of DNA synthesis, cell division and epidermal turnover.

Read about Methoxsalen

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
OXSORALEN-ULTRA Capsule FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D05BA02 Methoxsalen D Dermatologicals → D05 Antipsoriatics → D05B Antipsoriatics for systemic use → D05BA Psoralens for systemic use
Discover more medicines within D05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 503120120001517
Country: JP 医薬品医療機器総合機構 Identifier(s): 2699002F1046, 2699701M1021, 2699701Q1023, 2699701Q2038
Country: MT Medicines Authority Identifier(s): AA565/56701, AA565/56702
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100050756
Country: US FDA, National Drug Code Identifier(s): 0187-0650

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.